Showing results (81-90 of 242) with videos related to
Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
Intraperitoneal cytosine arabinoside therapy in ovarian carcinomaM E King, C E Pfeifle, S B HowellCancer Communications|January 1, 1990
The effect of DNA polymerase inhibitors on the cytotoxicity of cisplatin in human ovarian carcinoma cellsE J Katz, P A Andrews, S B HowellEuropean Journal of Cancer & Clinical Oncology|April 1, 1989
Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cellsP A Andrews, M P Murphy, S B HowellMolecular Pharmacology|August 27, 1999
Molecular modeling of the intrastrand guanine-guanine DNA adducts produced by cisplatin and oxaliplatinE D Scheeff, J M Briggs, S B HowellMedical and Pediatric Oncology|January 1, 1982
Modulation of the cellular pharmacology and clinical toxicity of 1-beta-D-arabinofuranosylcytosineS B Howell, J A Streifel, C E PfeifleInternational Journal of Cancer|July 30, 1991
Modulation of cis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cellsS C Mann, P A Andrews, S B HowellCancer|July 1, 1986
Cisplatin administered by the intracavitary route as treatment for malignant mesotheliomaM Markman, S Cleary, C Pfeifle, et al.Clinical Pharmacology and Therapeutics|November 1, 1979
Effect of probenecid on cerebrospinal fluid methotrexate kineticsS B Howell, R A Olshen, J A RiceCancer Research|December 1, 1985
Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletionP A Andrews, M P Murphy, S B HowellJournal of the National Cancer Institute|January 1, 1981
Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cellsB C Chu, C C Fan, S B HowellPageof 25